Introduction
spheres of baboons caused the formation of a 1.5-2.0 cm In anticipation of clinical trials of the safety of adenonecrotic cavity. When two animals that received intracervirus-mediated gene transfer in humans with malignant ebral injections of 1.5 × 10 9 p.f.u. were treated with 10 brain tumors we examined the neurotoxicity of the vector mg/kg of GCV twice daily they died from increased in cotton rats, a semipermissive host for adenoviral infecintracranial pressure. Intracerebral injections of 7.5 × 10 7 tion. 1, 2 The adenoviral vector (Adv.RSVtk) contained the p.f.u. (1.5 × 10 9 particles) and administration of GCV (10 gene for herpes simplex virus thymidine kinase (HSVtk) mg/kg twice daily for 14 days) did not cause necrotic driven by the Rous sarcoma virus (RSV) long terminal cavity formation or death. Baboons are not permissive for repeat promoter. HSVtk initiates phosphorylation of the adenoviruses so the neurotoxicity observed was attriguanine analog ganciclovir (GCV) 3 that is incorporated buted to direct cytopathic effect. Limited inflammation into newly synthesized DNA of rapidly dividing cells restricted to the injection site was observed in the brains and in turn kills the cells. 4, 5 In the brain most of the norof rats and mice when Adv.RSVtk was injected into normal cells are nondividing, while cells of a tumor are rapmal brain. 7, 11 idly dividing. Hence, normal cells expressing HSVtk and Byrnes and colleagues 14, 15 have shown in Albino converting GCV to its phosphorylated form will not be Oxford rats that peripheral administration of an adenovidamaged but tumor cells expressing HSVtk and conral vector carrying the E. coli ␤-galactosidase gene followverting GCV will be killed. Several laboratories have ing previous brain inoculation with the same vector reported preclinical data using retroviral or adenoviral incites a vigorous recrudescence of the CNS inflammavectors to transduce experimental brain tumors with tory response at the injection site and around neurons HSVtk indicating that this approach may be effective in capable of transporting the vector from the injection site. treating human brain tumors. [6] [7] [8] [9] [10] [11] [12] In previous experiments Some demyelination was seen in the areas of inflamwe found neurotoxicity of Adv.RSVtk in the nonhuman mation and along the injection tract through the corpus primate brain. 13 Injection of 1. 16 demonstrated in cotton rats that E1A deletion reduced the dissemination of adenoviral vectors after intravenous and intramuscular injection but that several organs, including lymph nodes, harbored vector and could be sites for trans complementation with wild-type virus. However, they showed that superinfection by intranasal inoculation of cotton rats with wild-type virus after intravenous and intramuscular inoculation resulted in no measurable evidence of complementation. 17 Extending the work of Oulikene and colleagues to the nervous system, we tested the toxicity of the Adv.RSVtk vector in cotton rats after direct injection into the brain. Vector was injected at the doses we anticipate will be tested in humans (5 × 10 6 and 7.5 × 10 7 p.f.u.), with and without co-administration of GCV, and with and without pre-immunization with wild-type adenovirus.
Results
Toxic effects of vector ± GCV Two groups of nine rats each were injected intracerebrally with 5.0 × 10 6 or 7.5 × 10 7 p.f.u. of Adv.RSVtk. Starting the following day, six animals in each group were treated with GCV (10 mg/kg, i.p., twice a day for 6 days) and the remaining three animals of each group were injected with saline (i.p., twice a day for 6 days) for 6 consecutive days. The animals were observed daily for clinical signs of illness. No illness was observed. Twelve days after vector injection the brains and lungs of the three saline control animals from each group and six of the GCV-treated animals from each group were inspected for pathology. Four weeks after vector injection the brains and lungs of the remaining three animals from each GCV-treated group were inspected for pathology. No demyelination, viral inclusions, cerebral edema, necrosis, cavities or vascular necrosis were seen in the brains of control or experimental animals. Lymphocytic and macrophage infiltrate and gliosis were seen at the injection sites (Figure 1 ), the ventricles were enlarged, and the ependyma and choroid plexus were inflamed ( Figure 1 , Table 1a ). The inflammation was not significantly different in rats treated with 5 × 10 6 or with 7.5 × 10 7 p.f.u. No inflammation, bronchitis, bronchopneumonitis or pneumonitis was observed in the lungs. 
Effects of pre-immunization with wild-type virus on (A) Coronal section through injection tract and lateral ventricle (v). The vector toxicity in the CNS injection tract is marked by carbon particles (white arrows). The ventricle
Six rats were immunized with wild-type Ad5 by intra- immunized control rats and the antibody titers to Ad5 were determined. All animals inoculated with wild-type adenovirus had antibodies to adenovirus (titers, 4.2 ± 1.48) in their sera while the control animals had no of Adv.RSVtk and GCV for treatment of malignant Twelve days after vector injection the brains and lungs tumors of the CNS we have tested the toxicity of the of three non-immunized rats and three immunized rats treatment in cotton rats, the only laboratory animal were inspected for pathology. Four weeks after vector known to be semipermissive for this adenoviral strain. 1, 2 injection the brains and lungs of the remaining three The major neuropathology observed in all of the experiimmunized rats were analyzed as above. None of the animents in which Adv.RSVtk was injected into the brains mals showed behavioral signs indicating adverse effects.
of cotton rats was an enlargement of the cerebral venAgain, no neuropathology was observed in the brain tricles and inflammation of the ependymal lining of the except for enlarged ventricles and infiltration of lymphoventricles, choroid plexus and of the brain parenchyma cytes and macrophages and gliosis at the injection track at the injection site. The development of enlarged venand in the ependyma and the choroid plexus (Table 1b) . tricles in animals after intracerebral injections of There was no significant difference in the degree of Adv.RSVtk is most likely due to changes in the balance inflammation in the animals that were pre-immunized between the formation and resorption of cerebral spinal with Ad5 and in those animals that were not. No lung fluid (CSF) as a result of the inflammation of the epenpathology was observed. dyma and choroid plexus. No demyelination, viral inclusions, cerebral edema, brain or vascular necrosis, or cavity formation was observed. The results were statistiTime course of vector neurotoxicity Twelve rats were injected intracerebrally with 7.5 × 10 7 cally similar whether or not the animals were treated with GCV, or pre-immunized with wild-type adenovirus. p.f.u. of Adv.RSVtk and treated with GCV (10 mg/kg, i.p., twice a day for 6 days). Three rats were killed on
The observation of inflammation of the ependyma and of the choroid plexus was unique to this species. In preeach of 4 days (1, 4, 12 and 28 days) after injection and were examined for lung and brain pathology and with vious experiments with nude mice, 7 Fischer rats, 11 and baboons, 13 intracerebral injections of Adv.RSVtk and plaque assays of lung homogenates for virus. No behavioral signs that suggested adverse effects, no lung GCV administration caused damage confined to the injection sites. Injections of Adv.RSVtk into the cerebral hemipathology, and no brain pathology except that associated with the injection tracks, the ependyma and the choroid spheres of nude mice caused limited gliosis at the injection site and no inflammation. Injections of the vector into plexus, was observed in the animals. The ventricles were enlarged and the ependyma and the choroid plexus were the caudate nucleus of Fischer rats caused inflammation and gliosis at the injection site but none distant. Intracerinflamed (Table 1c) brain tissue around the injection site was seen in cotton (HEp-2) obtained from the American Type Culture Collection (ATCC). When cytopathic effects (CPE) in these rats in a manner similar to the mouse, rat and baboon. In all four species the inflammation, gliosis and necrosis cultures attained 80-100% (usually after 5 to 7 days), the medium and the cells in each culture were collected, at the site of injection can be attributed to cytopathic effect of the vector.
placed in a Branson sonicating water bath (model B-220, Shelton, CT, USA) and exposed to six 15-s bursts of sonicThe ependymal and choroid plexus inflammation that was found in the cotton rat may arise from an increased ation (50/60 Hz). Each preparation was then centrifuged (480 g) to remove particulate matter. The resulting superinflammatory response to the cytopathic effect or an additional mechanism present in cotton rats. Pathology natants were filtered through a 0.45 m filter, portioned, labeled and stored at −70°C. Adv.RSVtk was generated due to replicating virus is unlikely since no evidence of replicating virus was observed in these animals either by by cotransfection of 293 cells with pADL.1/RSVtk and pJM17. 7, 18 Clinical grade vector was prepared using Good microscopic analysis or by plaque assay of tissue homogenates. In rats and mice the cells of the ependyma and Laboratory Practice (GLP) in Baylor College of Medicine's Gene Vector Laboratory. The vector preparation choroid plexus are tropic for adenoviral infection. It is possible that some vector leaked from the injection site contained 7.5 × 10 9 p.f.u./ml and 1.5 × 10 11 particles per milliliter. We verified that the vector preparation did not into the adjacent lateral ventricle where it was disseminated throughout the ventricles via the cerebrospinal contain measurable wild-type contamination or E1A recombination from 293 cells by polymerase chain reacfluid and infected the ependymal lining and choroid plexus. The infected ependymal and choroid plexus cells tion (PCR) for the wild-type E1A sequence. The detection limit of this assay is 10 3 viral particles, which translates of the cotton rat may be very sensitive to adenoviral infection, or to the HSVtk expressed by the transduced to an assay sensitivity of one wild-type adenoviral genome per 10 6 vector particles. 13 cells which, in turn, resulted in cell death and inflammation. Whatever the mechanism of ependymal and choroid plexus inflammation the effects caused no observAnimal studies able clinical response in these animals. Additionally, no
Cotton rats (Sigmodon hispidus) used in these studies were peripheral histopathology was seen in these animals. In descendants of two pairs of animals obtained in 1984 agreement with the experiments of Oualikene and colfrom the Small Animal Section of the Veterinary Research leagues 16, 17 there was no evidence of E1 complementation Branch, Division of Research Services, National Institutes of the vector.
of Health. They were bred and studies were performed Viral vector injected into the brain incites a prompt and in laboratory facilities accredited by the American Associvigorous inflammatory reaction at the injection site and ation of the Accreditation for Laboratory Animal Care in transfected cells distant from the site of injection. The (AAALAC) at Baylor College of Medicine. Before intradegree and specificity of the distant cell involvement cerebral injections of Adv.RSVtk the adult cotton rats depends on the particular cellular tropisms of the vectors were calmed with CO 2 and then anesthetized with an employed. With Adv.RSVtk, the ependyma and choroid intramuscular injection (0.6 ml/kg) of an anesthetic conplexus are uniformly involved, and only rare transfected sisting of ketamine (42.8 mg/ml), xylazine (8.6 mg/ml), neurons and astrocytes are targeted by the inflammatory and acepromazine (1.4 mg/ml). The rats' heads were reaction. Our experiments did not demonstrate a heightplaced in a stereotactic frame and a mid-line incision was ened inflammatory response in cotton rats pre-immunmade in the scalp. A burr hole was made with a 0.9 mm ized with wild-type adenovirus. This would indicate that drill bit 2.2 mm to the right and 1.0 mm anterior to the prior exposure to wild-type adenovirus may not pose a bregma. major risk in terms of increased inflammatory reaction.
Using a 10 l syringe connected to the manipulating The scenario of exposure to wild-type adenovirus folarm of the stereotactic frame the vector was injected lowing intracerebral injection of Adv.RSVtk has not been through a 26-gauge needle at a depth of 3.2 mm at a rate explicitly addressed in our study. Byrnes and colleagues' of 1.0 l/min. After the injection was completed the finding of recurrent inflammation after peripheral adminneedle was left in place for 3 min and then slowly istration of adenoviral vector would compel careful removed from the brain. A small amount of ground stermonitoring of patients for several weeks to months folile charcoal (Ͻ30 m) was placed on the tip of the needle lowing intracerebral Adv.RSVtk injection for the acquibefore the injection to mark the injection site and track. sition of banal wild-type viral infections. However, it is
The scalp wound was closed with clips. possible that recrudescence of the inflammatory response Animals were inoculated with wild-type virus by pipin a residual tumor might in fact augment the therapeutic etting the virus into the nostrils while the animals were effect of the gene therapy for brain tumors, as the under metofane anesthesia. Blood was collected from the immunologic response to the therapy appears to be a orbital sinus plexus under CO 2 anesthesia. After clotting component of the 'bystander effect'. and centrifugation, sera were collected and heat inactiThe results of these and other experiments 16, 17 with anivated at 56°C for 30 min. GCV was administered by i.p. mals semipermissive to adenoviral infections indicate injection twice daily under CO 2 anesthesia. Before collecthat adenoviral vectors have limited neurotoxicity which tion of tissues for plaque assays the cotton rats were aneswould not appear to prohibit their use in limited phase thetized with halothane and then decapitated. I clinical trials in humans.
Plaque assay of lung tissue

Materials and methods
Lungs were removed aseptically, frozen on dry ice and stored at −70°C until analysis. They were thawed and Adenovirus virus and vector construction and preparation placed in sterile tubes containing 1 ml of sterile minimal essential medium with Earle's salts (MEM) supplemented Working stocks of wild-type adenovirus (Ad5) were prepared by infecting monolayers of human epithelial cells with 2% fetal calf serum (FCS) . Sterile glass beads were added to the tubes and the tubes were then placed in a Chen is an Associate and SLC Woo is an Investigator of Mini-beadbeater (Biospec Products, Bartlesville, OK, the Howard Hughes Medical Institute. USA) and homogenized by rapid shaking for 2 min. Cultures of 293 cells purchased from ATCC were grown in Dulbecco's modified Eagle's medium (D-MEM) sup-
